One thing I’ve noticed in the last fifteen years is how aware Americans have become of health policy issues. When I first told people as an undergrad that I wanted to pursue a career in health policy, I almost always received glazed looks in response. “What would that look like exactly?” Now, virtually everyone I meet (Lyft drivers, new friends at get-togethers, strangers on the plane, new colleagues) has an opinion, when they learn that I am a nephrologist and health policy researcher.
The American Academy of Pediatrics (AAP), in conjunction with the American Society of Pediatric Nephrology (ASPN), as part of the Choosing Wisely® campaign, recently “released a list of specific nephrology tests and procedures that are commonly ordered but not always necessary when treating children for kidney-related conditions”.
The Choosing Wisely recommendations include:
Choosing Wisely® is an initiative of the ABIM Foundation, which seeks to promote conversations between clinicians and patients in choosing care that is supported by evidence; does not duplicate other tests or procedures already received; is free from harm; and truly necessary.
Per the July 2nd, 2018 press release from The Declaration of Istanbul:
"The first new edition of the Declaration of Istanbul on Organ Trafficking and Transplant Tourism, a seminal document that has helped to guide ethical practice in organ donation and transplantation around the world, was presented today at an international workshop in Madrid, Spain.
The Declaration was originally published in 2008, following a summit convened by The Transplantation Society (TTS) and the International Society of Nephrology (ISN) in response to growing concerns about international trafficking in human organs. It established definitions of practices such as transplant tourism and organ trafficking, and principles to guide policy makers and health professionals working in organ donation and transplantation. Since 2008, more than 135 professional societies have formally endorsed the Declaration.
Today, June 22nd 2018, the US House of Representatives passed H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. H.R. 6 combines more than 50 bills approved individually by the House.
The bipartisan bill is designed to help overall efforts to combat the opioid crisis by advancing treatment and recovery initiatives, bolstering prevention efforts, and trying to counter deadly illicit synthetic drugs like fentanyl.
In this complimentary webinar, review the critical role that nephrologists and dialysis professionals have in preventing infections. Examine the CDC's recommendations for dialysis station disinfection and compare your medical facility's policies with environmental disinfection best practices. Discover the patient perspective on environmental cleanliness and learn how nephrologists can take a leadership role in facility sanitization.